Two Sigma Advisers LP Has $2.61 Million Stock Holdings in eHealth, Inc. (NASDAQ:EHTH)

Two Sigma Advisers LP grew its holdings in eHealth, Inc. (NASDAQ:EHTH - Free Report) by 86.6% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 277,700 shares of the financial services provider's stock after buying an additional 128,900 shares during the quarter. Two Sigma Advisers LP owned 0.94% of eHealth worth $2,610,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in the business. American Century Companies Inc. grew its holdings in shares of eHealth by 4.0% in the 4th quarter. American Century Companies Inc. now owns 46,422 shares of the financial services provider's stock worth $436,000 after purchasing an additional 1,772 shares during the last quarter. R Squared Ltd bought a new stake in shares of eHealth in the 4th quarter worth about $29,000. Sei Investments Co. grew its holdings in shares of eHealth by 5.3% in the 4th quarter. Sei Investments Co. now owns 110,728 shares of the financial services provider's stock worth $1,041,000 after purchasing an additional 5,622 shares during the last quarter. Jump Financial LLC grew its holdings in shares of eHealth by 34.8% in the 4th quarter. Jump Financial LLC now owns 29,710 shares of the financial services provider's stock worth $279,000 after purchasing an additional 7,678 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in shares of eHealth by 2.4% in the 4th quarter. Geode Capital Management LLC now owns 325,972 shares of the financial services provider's stock worth $3,065,000 after purchasing an additional 7,680 shares during the last quarter. Institutional investors and hedge funds own 79.54% of the company's stock.

Analysts Set New Price Targets

EHTH has been the topic of several analyst reports. UBS Group lowered their target price on shares of eHealth from $9.50 to $7.00 and set a "neutral" rating on the stock in a report on Thursday, May 8th. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $11.00 target price on shares of eHealth in a report on Monday, May 19th. Finally, Wall Street Zen lowered shares of eHealth from a "buy" rating to a "hold" rating in a report on Sunday, May 11th. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $6.75.

eHealth Price Performance

NASDAQ:EHTH traded up $0.14 during mid-day trading on Thursday, reaching $4.35. 255,478 shares of the company were exchanged, compared to its average volume of 267,217. eHealth, Inc. has a 12 month low of $3.58 and a 12 month high of $11.36. The company has a fifty day moving average of $5.60 and a 200 day moving average of $7.29. The company has a quick ratio of 3.10, a current ratio of 3.10 and a debt-to-equity ratio of 0.14. The stock has a market cap of $131.92 million, a PE ratio of -1.53 and a beta of 1.11.

eHealth (NASDAQ:EHTH - Get Free Report) last issued its earnings results on Wednesday, May 7th. The financial services provider reported ($0.33) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.41) by $0.08. The company had revenue of $113.12 million for the quarter, compared to analyst estimates of $99.46 million. eHealth had a negative net margin of 7.58% and a negative return on equity of 5.70%. On average, research analysts anticipate that eHealth, Inc. will post -2.17 EPS for the current fiscal year.

eHealth Profile

eHealth, Inc operates a health insurance marketplace that provides consumer engagement, education, and health insurance enrollment solutions in the United States. The company operates in two segments, Medicare; and Employer and Individual. The Medicare segment offers sale of Medicare-related health insurance plans, which includes Medicare advantage, Medicare Supplement, and Medicare Part D prescription drug plans to Medicare-eligible customers including but not limited to, dental, and vision insurance, as well as advertising program for marketing and other services.